Invokana Lawsuit: Plaintiff Alleges Side Effects Including Kidney Failure Requiring Kidney Transplant
April 29, 2016 – – TheProductLawyers.com reports on an Invokana lawsuit plaintiff’s allegation which claims that there is a link between new-generation diabetes drug Invokana, made by Janssen Pharmaceuticals, and kidney failure. The plaintiff alleges that users of Invokana can suffer kidney damage and failure due to their use of the drug. In addition to the plaintiff’s allegations the FDA has reported receiving 50 reports which relate to kidney failure and renal impairment from patients who have taken the drug.
Invokana is in a class of drugs known as SGLT2 inhibitors which are designed to help maintain control of blood sugar levels. This is done by keeping excess glucose from being reabsorbed into the kidneys. Instead, it uses the kidneys to push that excess glucose out of the body, through urination. In order to accomplish this excess work is required from the kidneys. As a possible result of this excess strain there have been many cases of kidney damage which can cause kidney failure if left untreated.
Approximately 6 months ago, the FDA announced new requirements for the warning labels of Invokana, requiring the manufacturer of the drug to adjust them to contain information related to the possible side effects being reported. The primary effects that were required to be listed were ketoacidosis and urinary tract infections, which have been reported in a high numbers of patients who have taken the drug.
The FDA has also stated that they received a total of 19 adverse event reports in which individuals sustained additional serious potentially life-threatening problems which began as urinary tract infections. These health problems then developed into kidney infections and blood infections that required hospitalization and dialysis for kidney failure. Kidney damage is not able to be repaired, so those who suffer from extreme damage and kidney failure would likely require a complete kidney transplant.
For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792
###
Contact TheProductLawyers.com:
Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023
ReleaseID: 60009591